Related Experiment Video
Updated: Mar 6, 2026

07:37
Roux-en-Y Gastric Bypass Operation in Rats
Published on: June 11, 2012
24.4K
Impulsivity predicts weight loss after obesity surgery.
Myutan Kulendran1, Leah Borovoi2, Sanjay Purkayastha1
1Imperial College London, London, United Kingdom.
Summary
Impulsivity and inhibitory control predict weight loss after bariatric surgery. Improved self-control is linked to greater BMI reduction, offering insights for obesity treatment outcomes.
Area of Science:
- Behavioral Science
- Clinical Psychology
- Obesity Research
Background:
- Executive function, particularly inhibitory control, is linked to obesity and eating behaviors.
- While bariatric surgery yields significant weight loss, the influence of personality traits on outcomes remains unclear.
- The specific impact of impulsivity on post-bariatric surgery weight reduction is not well understood.
Purpose of the Study:
- To investigate if personality traits and inhibitory control predict weight loss following bariatric procedures.
- To explore the relationship between impulsivity, inhibitory control, and BMI reduction in bariatric patients.
Main Methods:
- Forty-five bariatric patients (gastric bypass and sleeve gastrectomy) were recruited.
- Participants completed measures of impulsivity (Barratt's Impulsivity Scale) and inhibitory control (stop-signal reaction-time task).
- Measures were analyzed in relation to body mass index (BMI) changes six months post-surgery.
Main Results:
- Both the surgical procedure and changes in inhibitory control (SSRT) significantly predicted BMI reduction.
- Gastric bypass resulted in a 25% BMI reduction, significantly greater than the 14.1% reduction seen with sleeve gastrectomy.
- Increased pre- and post-operative inhibitory control (reduced impulsivity) positively correlated with greater BMI reduction.
Conclusions:
- Impulsivity measures are significant predictors of weight reduction after bariatric surgery.
- These findings have implications for predicting the success of surgical interventions for obesity.
- Assessing pre-operative impulsivity and inhibitory control may aid in patient selection and post-operative management.
Related Concept Videos
Bulimia Nervosa
910
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
910
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
331
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
331
Binge Eating Disorders
635
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
635
Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
259
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
259
Drug Dosing: Obese Patients
320
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
320

